Over the years the field of medicine has undergone innumerable technological advancements with the development of novel drugs and advanced treatments that are focused not only on cure, but also on prevention. However, the rising geriatric population, increasing prevalence of chronic and infectious diseases, and the inability of existing therapies to identify the root-cause of diseases has propelled the need for the development and adoption of more advanced and sensitive tools and treatment approaches such as precision and regenerative medicines in the healthcare industry.
Regenerative medicine is based on cell-analysis, which can be defined as an ultra-sensitive tool offering a wide range of applications such as protein and gene identification, transcriptional analysis, mapping of the biochemical and physical processes of the patient life, revealing the nature of cell heterogeneity, and pathways for proper evaluation and diagnosis of diseases.
Moreover, the data collected through the applications of cell analysis helps in identifying, predicting, and manipulating the factors affecting the health, proliferation, function, and death of cells in a human body.
According to the latest market intelligence report by BIS Research titled “Latin America Cell Analysis Market – Analysis and Forecast, 2019-2025,” the Latin America cell analysis market was valued at $720.3 million in 2017, is anticipated to grow at a CAGR of 10.29% during the forecast period, 2019-2025, to reach $1,566.7 million by 2025.
Factors driving the growth of the Latin America cell analysis market include the increased precision of cell analysis systems which have reduced the cost and time associated with the drug delivery process, significant investments from the government in the research of single-cell analysis technique, and escalating innovations in reagents and assay kits.
In addition to these factors, technological advancements and innovation of instruments, and new product launches have also fueled the growth of the Latin America cell analysis market.
Some of the recent product launches in the Latin America cell analysis market include the microfluidic system named CellASIC ONIX2 launched by Merck KGaA for advanced live-cell imaging and the Gen5 3.0 data analysis software for accurate imaging and microplate detection instruments launched by BioTek Instruments.
The report by BIS Research studies the key cell analysis techniques including cell viability, cell proliferation, cell counting and quality control, cell interaction, single-cell analysis, and cell signaling pathways. Along with a detailed examination of the cell analysis process, the report also provides a holistic view of the Latin America cell analysis market through its segmentations as product type, end-user, and country and also covers key trends and growth of the market, company profiles of leading market players, along with the strategies and developments undertaken the key players present in the market.
Cell analysis is emerging as a solution for the expensive treatments burdening the healthcare system and is expected to witness a tremendous growth in the near future.